Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Janzen

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Chemistry & Biology|September 20, 2014
Screening technologies for small molecule discovery: the state of the artWilliam P Janzen
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
High throughput screening. Methods and protocols, second edition. PrefaceWilliam P Janzen, Paul Bernasconi
Chemical Biology & Drug Design|February 24, 2006
A chemogenomic approach to discovering target-selective drugsWilliam P Janzen, C Nicholas Hodge
Journal of Biomolecular Screening|June 2, 2009
Advances in improving the quality and flexibility of compound managementWilliam P Janzen, Ioana G Popa-Burke
Life Sciences|May 6, 2008
The use of diversity profiling to characterize chemical modulators of the histone deacetylasesLeonard Blackwell, Jacqueline Norris, Carla M Suto, et al.
Drug Discovery Today. Technologies|January 19, 2011
Epigenetics: Tools and TechnologiesWilliam P Janzen, Tim J Wigle, Jian Jin, et al.
Nature Reviews. Drug Discovery|November 21, 2015
Towards a hit for every targetSteve Rees, Philip Gribbon, Karen Birmingham, et al.
Assay and Drug Development Technologies|December 24, 2011
High-throughput screening for RecA inhibitors using a transcreener adenosine 5'-O-diphosphate assayEliza J R Peterson, William P Janzen, Dmitri Kireev, et al.
Electrophoresis|February 26, 2008
Photobleaching-based flow measurement in a commercial capillary electrophoresis chip instrumentGuiren R Wang, Ian Sas, Hong Jiang, et al.
Journal of Medicinal Chemistry|October 12, 2010
Identification of non-peptide malignant brain tumor (MBT) repeat antagonists by virtual screening of commercially available compoundsDmitri Kireev, Tim J Wigle, Jacqueline Norris-Drouin, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Chemistry & Biology|September 20, 2014
Screening technologies for small molecule discovery: the state of the artWilliam P Janzen
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
High throughput screening. Methods and protocols, second edition. PrefaceWilliam P Janzen, Paul Bernasconi
Chemical Biology & Drug Design|February 24, 2006
A chemogenomic approach to discovering target-selective drugsWilliam P Janzen, C Nicholas Hodge
Journal of Biomolecular Screening|June 2, 2009
Advances in improving the quality and flexibility of compound managementWilliam P Janzen, Ioana G Popa-Burke
Life Sciences|May 6, 2008
The use of diversity profiling to characterize chemical modulators of the histone deacetylasesLeonard Blackwell, Jacqueline Norris, Carla M Suto, et al.
Drug Discovery Today. Technologies|January 19, 2011
Epigenetics: Tools and TechnologiesWilliam P Janzen, Tim J Wigle, Jian Jin, et al.
Nature Reviews. Drug Discovery|November 21, 2015
Towards a hit for every targetSteve Rees, Philip Gribbon, Karen Birmingham, et al.
Assay and Drug Development Technologies|December 24, 2011
High-throughput screening for RecA inhibitors using a transcreener adenosine 5'-O-diphosphate assayEliza J R Peterson, William P Janzen, Dmitri Kireev, et al.
Electrophoresis|February 26, 2008
Photobleaching-based flow measurement in a commercial capillary electrophoresis chip instrumentGuiren R Wang, Ian Sas, Hong Jiang, et al.
Journal of Medicinal Chemistry|October 12, 2010
Identification of non-peptide malignant brain tumor (MBT) repeat antagonists by virtual screening of commercially available compoundsDmitri Kireev, Tim J Wigle, Jacqueline Norris-Drouin, et al.
Pageof 5